Publication:
Assessment of side effects (SEs) impacting quality of life (QoL) in patients (pts) undergoing treatment (tx) for advanced breast cancer (ABC) in clinical practice: A real-world (RW) multi-country survey

Simple item page
dc.conference.dateMAY 03-05, 2022
dc.conference.titleEuropean-Society-for-Medical-Oncology (ESMO) Breast Cancer Congress
dc.contributor.authorCardoso, F.
dc.contributor.authorRihani, J.
dc.contributor.authorAubel, D.
dc.contributor.authorde Courcy, J.
dc.contributor.authorHarmer, V.
dc.contributor.authorHarbeck, N.
dc.contributor.authorCasas, A.
dc.contributor.authorRugo, H. S.
dc.contributor.authorFasching, P. A.
dc.contributor.authorHaftchenary, S.
dc.contributor.authorPathak, P.
dc.contributor.authorSchumacher-Wulf, E.
dc.contributor.authoraffiliation[Cardoso, F.] Champalimaud Fdn Champalimaud Clin Ctr, Breast Unit, Lisbon, Portugal
dc.contributor.authoraffiliation[Rihani, J.] KHCC King Hussein Canc Ctr, Oncol, Amman, Jordan
dc.contributor.authoraffiliation[Aubel, D.] Novartis Pharmaceut, Oncol, E Hanover, NJ USA
dc.contributor.authoraffiliation[de Courcy, J.] Adelphi Real World Grp, Oncol, Bollington, England
dc.contributor.authoraffiliation[Harmer, V.] Imperial Coll Healthcare NHS Trust Charing Cross, Breast Serv Unit, London, England
dc.contributor.authoraffiliation[Harbeck, N.] Ludwig Maximilians Univ Grosshadern, Breast Ctr, Munich, Germany
dc.contributor.authoraffiliation[Casas, A.] Hosp Univ Virgen del Rocio, Oncol, Seville, Spain
dc.contributor.authoraffiliation[Rugo, H. S.] UCSF Helen Diller Family Comprehens Canc Ctr, Breast Dept, San Francisco, CA USA
dc.contributor.authoraffiliation[Fasching, P. A.] Univ Klinikum Erlangen, Dept Gynecol & Obstet, Erlangen, Germany
dc.contributor.authoraffiliation[Haftchenary, S.] Novartis Pharma Canada, Oncol, Dorval, PQ, Canada
dc.contributor.authoraffiliation[Pathak, P.] Novartis Ireland Ltd, HEOR, Dublin, Ireland
dc.contributor.authoraffiliation[Schumacher-Wulf, E.] Mamma MIA Breast Canc Magazine, Oncol, Cologne, Germany
dc.date.accessioned2023-05-03T14:40:15Z
dc.date.available2023-05-03T14:40:15Z
dc.date.issued2022-05-05
dc.identifier.doi10.1016/j.annonc.2022.03.197
dc.identifier.essn1569-8041
dc.identifier.issn0923-7534
dc.identifier.unpaywallURLhttp://www.annalsofoncology.org/article/S0923753422005762/pdf
dc.identifier.urihttp://hdl.handle.net/10668/21905
dc.identifier.wosID792494100181
dc.issue.number3
dc.journal.titleAnnals of oncology
dc.journal.titleabbreviationAnn. oncol.
dc.language.isoen
dc.organizationHospital Universitario Virgen del Rocío
dc.organizationHospital Universitario Virgen del Rocío
dc.page.numberS208-S209
dc.publisherElsevier
dc.rights.accessRightsopen access
dc.titleAssessment of side effects (SEs) impacting quality of life (QoL) in patients (pts) undergoing treatment (tx) for advanced breast cancer (ABC) in clinical practice: A real-world (RW) multi-country survey
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number33
dc.wostypeMeeting Abstract
dspace.entity.typePublication

Files

Collections

SAS - Hospital Universitario Virgen del Rocío

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía